These findings suggest a mechanism of FKBP5-mediated chemoresistance that involves intricate protein–protein interactions and transcriptional regulation, suggesting promising therapeutic opportunities for addressing drug resistance in ovarian cancer. The gene discussed is FKBP5; the disease is ovarian cancer.